4 Biotechs Ready to Kill the Market in 2018 Post author:Sam Post published:December 28, 2017 Post category:BioPharma A look at a few biotechs which should outperform the market in 2018: Source: BioSpace You Might Also Like After FDA Rejection, Bay Area's Coherus Axes 30% of Employees June 27, 2017 Eleven Bio Reports Fourth Quarter And Full Year 2016 Financial Results March 23, 2017 Lilly Exploring Strategic Alternatives for Animal Health Biz January 31, 2018
